Discovery of metastases in thyroid cancer and "benign metastasizing goiter": a historical note.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 12 12 2023
accepted: 21 03 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: epublish

Résumé

At the beginning of the eighteenth century, most physicians recognized cancer as an aggressive process that gradually spreads, leading to cachexia and death. Thyroid malignancies had long been underestimated because the majority of the population of West Europe suffered from diffuse goiters that masked malignant processes in the neck. Moreover, the life expectancy at that time was very low (about 37-40 years), so the majority of people died of other causes before metastatic thyroid cancer could develop and manifest. Nevertheless, in 1817, French dermatologist Jean Louis Alibert described the first case of a malignant tumor involving the thyroid gland. From the 1820s the number of case reports describing thyroid cancer increased. Even though Jean Claude Recamier described

Identifiants

pubmed: 38756996
doi: 10.3389/fendo.2024.1354750
pmc: PMC11096462
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1354750

Informations de copyright

Copyright © 2024 Kushchayev, Kushchayeva, Glushko, Pestun and Teytelboym.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Sergiy Kushchayev (S)

Diabetes and Endocrinology Center, University of South Florida, Tampa, FL, United States.

Yevgeniya Kushchayeva (Y)

Department of Radiology, Moffitt Cancer Center, Tampa, FL, United States.

Tetiana Glushko (T)

Department of Radiology, Moffitt Cancer Center, Tampa, FL, United States.

Iryna Pestun (I)

Diabetes and Endocrinology Center, University of South Florida, Tampa, FL, United States.

Oleg Teytelboym (O)

Department of Radiology, Mercy Catholic Medical Center, Philadelphia, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH